What’s the current market cap for AMN Healthcare stock?

AMN Healthcare (AMN) has a market cap of $1.2bn as of June 17, 2026.

What is the P/E ratio for AMN Healthcare stock?

The price to earnings (P/E) ratio for AMN Healthcare (AMN) stock is 0 as of June 17, 2026.

Does AMN Healthcare stock pay dividends?

No, AMN Healthcare (AMN) stock does not pay dividends to its shareholders as of June 17, 2026.

When is the next AMN Healthcare dividend payment date?

AMN Healthcare (AMN) stock does not pay dividends to its shareholders.

What is the beta indicator for AMN Healthcare?

AMN Healthcare (AMN) has a beta rating of 0.3. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

Buy AMN Healthcare stock | $AMN Share Price

13:30

15:10

16:45

18:25

20:00

About AMN Healthcare

AMN Healthcare Services Inc provides healthcare workforce solutions and staffing services in the United States. Its comprehensive suite of talent solutions provides management, staffing, recruitment, language services, technology, predictive and market analytics, and related services to build and manage all or parts of the clients' healthcare workforce needs. Its reportable segments are: Nurse and Allied Solutions, Physician and Leadership Solutions, and Technology and Workforce Solutions. A majority of its revenue is generated from the Nurse and Allied Solutions segment, which includes the company's travel nurse staffing, labor disruption staffing, local staffing, international nurse permanent placement, and allied staffing (including revenue cycle solutions) businesses.

Ticker

$AMN

Sector

Health

Primary listing

NYSE

Employees

2,664

Headquarters

Dallas, United States

Website

www.amnhealthcare.com

AMN Healthcare Metrics

BasicAdvanced

$1.2bn

-$0.84

0.30

What the Analysts think about AMN Healthcare

Analyst ratings (Buy, Hold, Sell) for AMN Healthcare stock.

Bulls say / Bears say

AMN delivered adjusted EPS of $2.10 in Q1 2026, surpassing the IBES estimate of $1.62, marking a significant profitability recovery from the prior year (Reuters)

First-quarter revenue doubled year-over-year to $1.378 billion, driven by high-margin labor disruption events, outpacing the consensus estimate of $1.23 billion (Reuters)

The Nurse & Allied Solutions segment generated $1.127 billion in Q1, a 173% increase year-over-year and the second-highest quarterly total in company history, reflecting robust core staffing demand (Reuters)

Q2 2026 revenue guidance of $620 million to $635 million implies a more than 50% sequential decline from Q1’s $1.378 billion as non-recurring labor disruption projects normalize, raising sustainability concerns (Reuters)

Language services revenue declined 8% year-over-year and 1% sequentially in Q1 2026, while vendor management systems revenue dropped 18%, underscoring weakness in the Technology & Workforce Solutions segment (Reuters)

Labor disruption events contributed $722 million—over half of Q1 revenue—highlighting the company’s heavy reliance on non-recurring projects that may not recur, which could pressure organic growth once normalized (Reuters)

Data summarised monthly by Lightyear AI. Last updated on 24 May 2026.

AMN Healthcare Financial Performance

Revenues and expenses

QuarterlyAnnual

Q3 24

QoQ growth

Revenue

$37bn

-39.75%

Net income

$45bn

107.52%

Profit margin

37.65%

6.78%

AMN Healthcare Earnings Performance

Company profitability

QuarterlyAnnual

Q4 23

Q1 24

Q2 24

Q3 24

Q4 24

Actual

$3.69

$2.85

$2.45

$2.42

Expected

$3.55

$2.61

$2.05

$2.31

$3.94

Surprise

3.94%

9.20%

19.51%

4.63%

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.

Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $AMN

Capital at risk

Market closed

Upcoming events

No upcoming events

Bulls say / Bears say

AMN delivered adjusted EPS of $2.10 in Q1 2026, surpassing the IBES estimate of $1.62, marking a significant profitability recovery from the prior year (Reuters)

First-quarter revenue doubled year-over-year to $1.378 billion, driven by high-margin labor disruption events, outpacing the consensus estimate of $1.23 billion (Reuters)

Data summarised monthly by Lightyear AI. Last updated on 24 May 2026.